Try our Advanced Search for more refined results
Intellectual Property
-
November 08, 2024
Fed. Circ. Backs Invalidation Of Geolocation IP Under Alice
The Federal Circuit won't breathe new life into GeoComply's infringement suit against its geolocation competitor XPoint over an anti-location-spoofing patent, affirming a lower court's dismissal.
-
November 08, 2024
Fed. Circ. Unclear If Teva Inhaler IP Belongs In Orange Book
A trio of Federal Circuit judges took a complex question tied to whether Teva should be able to include inhaler patents in the U.S. Food and Drug Administration's Orange Book and tried to make it simple: Does owning a patent for a steering wheel mean you claim the whole car?
-
November 08, 2024
Facts In Emails Aren't Confidential For Deposition, Judge Says
A government contractor implicated in allegations that the U.S. infringed patents for contactless data carriers must turn over portions of a former employee's emails because the correspondence contains facts not protected by attorney-client privilege, the U.S. Court of Federal Claims has ruled.
-
November 08, 2024
Ex-Elanco IP Lawyer Lodges Gender Discrimination Suit
A female former in-house intellectual property lawyer at Elanco Animal Health Inc. sued the pharmaceutical company for gender discrimination in Indiana federal court, alleging she was passed over for a promotion in favor of a less qualified man who later mistreated the women on staff.
-
November 08, 2024
Chancery Tosses Microchip Co.'s Tech Licensor Challenge
A Delaware vice chancellor on Friday dismissed a lawsuit filed by Swiss microchip maker u-blox AG against tech licensor InterDigital Inc., finding among other points that u-blox was barred from moving forward with potentially unsettled claims arising from the same issues in a California federal court case.
-
November 08, 2024
Justices Urged To Review Amazon Patent Program Case
A company alleging patent infringement through Amazon's patent evaluation program is urging the U.S. Supreme Court to take up its appeal of a Federal Circuit ruling that said it had to face a declaratory judgment suit in the purported infringer's home state.
-
November 08, 2024
White & Case Adds Life Sciences IP Atty From A&O Shearman
A veteran life sciences patent litigator has jumped from Allen Overy Shearman Sterling to White & Case LLP in New York, expanding the firm’s capabilities to represent medical and pharmaceutical industry clients in complex litigation.
-
November 08, 2024
Logan Paul's Drink Co. Blasts Olympic Committee's TM Suit
Prime Hydration, a sports beverage company co-founded by social media influencer and wrestler Logan Paul, has struck back at a trademark infringement complaint from the United States Olympic & Paralympic Committee, accusing it of taking a "shotgun pleading" approach without supporting its claims.
-
November 08, 2024
New Patent Filings Hit Global Record, WIPO Says
A new report from the World Intellectual Property Organization has found that new patent filings worldwide reached a record high in 2023, as patent applications exceeded 3.5 million for the first time.
-
November 08, 2024
Disney Hit With Suit Over Streaming Media Patents
The Walt Disney Co. and subsidiaries like Hulu and ESPN have been hit with a federal lawsuit claiming that the entertainment giant's various streaming services infringe a series of media patents owned by Adeia Technologies Inc.
-
November 08, 2024
UK Litigation Roundup: Here's What You Missed In London
This past week in London has seen collapsed German airline Air Berlin take action against its former auditor KPMG, the associate editor at The Spectator hit with a libel claim by a mosque over the far-right riots that took place in August and British licensing authority the Performing Right Society sue Parklife Manchester and four other festival organizers. Here, Law360 looks at these and other new claims in the U.K.
-
November 07, 2024
Oakland Airport Name Has Travelers Flying In Circles, SF Says
Attorneys for San Francisco urged a California federal judge Thursday to block Oakland from renaming its airport the "San Francisco Bay Oakland International Airport," saying travelers are mistakenly showing up to San Francisco International Airport instead of Oakland's hub because the new name is "dangerously and confusingly similar."
-
November 07, 2024
OpenAI Beats Copyright Suit By 2 News Websites, For Now
OpenAI preliminarily escaped one of the many copyright suits it's facing from journalism publishers on Thursday, as a New York federal judge found that two alternative news websites didn't sufficiently allege harm from the removal of author information in ChatGPT training sets.
-
November 07, 2024
Teva Fails To Convince Judge Inhaler Patents Require Drug
Five patents for an inhaler made by Teva Pharmaceuticals Industries Ltd. don't require an active drug's presence in the device, a New Jersey federal judge has ruled, agreeing with Amneal Pharmaceuticals Inc.'s interpretation of claim language in the brand-name drugmaker's infringement suit against Amneal, a generic pharmaceutical firm.
-
November 07, 2024
Nike Nabs Injunction In Air Jordan Knockoff Suit But Not $4M
A New Jersey federal judge on Thursday barred a small clothing company and its founder from selling knockoffs of Nike's iconic Air Jordan 1 High sneakers but declined to grant Nike $4 million in statutory damages, saying Nike hadn't yet given him enough information to assess the damages.
-
November 07, 2024
Masimo Spinoff's Ex-CTO Denies Giving Apple Trade Secrets
Cercacor Laboratories' former chief technology officer testified Thursday that he privately emailed Apple CEO Tim Cook offering to help the tech giant become a top health and wellness device brand, but denied accusations that he gave Apple any of the Masimo spinoff's pulse oximetry trade secrets.
-
November 07, 2024
Santa May Come Early For Mariah Carey In 'Christmas' IP Suit
A California federal judge said Thursday that she is "inclined" to grant Mariah Carey and others a victory in a copyright infringement suit over her song "All I Want For Christmas Is You" and sanction the plaintiffs after the pop singer's side alleged they made legally frivolous arguments.
-
November 07, 2024
Litigation Funders Look For Attorneys They Can Trust
Litigation funders often see the attorneys they would be working with as the most important element of whether to invest in a case, several members of the industry said on a panel at the University of Texas School of Law's Advanced Patent Law Institute.
-
November 07, 2024
How Penn State Trial Against Retailer Could Upend TM Law
The Pennsylvania State University and an online retailer of goods bearing retro logos and images of schools and sports teams are set to clash in a trademark trial next week that could upend how courts examine infringement claims.
-
November 07, 2024
ITC Finds Innoscience Infringed Semiconductor Patent
The U.S. International Trade Commission has backed a finding that Innoscience flouted federal law by importing semiconductor technology that infringes an Efficient Power Conversion Corp. patent.
-
November 07, 2024
Fed. Circ. Questions Expert's Background In 4G Patent Case
A Federal Circuit judge suggested Thursday that the court might vacate a Patent Trial and Appeal Board decision partly invalidating a Sisvel 4G wireless patent challenged by Honeywell and others, saying the board relied on an expert who may not have the necessary qualifications.
-
November 07, 2024
ITC Finds Dell, ASUSTeK, Acer Imports Don't Infringe Patent
The U.S. International Trade Commission has found that various computer hardware companies, including Dell, never infringed claims in an X1 Discovery Inc. patent related to indexed searching by importing consumer products with certain Microsoft software.
-
November 07, 2024
Teva Can't End Inhaler Antitrust Suit But Gets Claim Nixed
A Massachusetts federal court refused Teva Pharmaceutical Industries Ltd.'s attempt to end a case accusing it of orchestrating a decade-long scheme to delay generic competition for its QVAR asthma inhalers, but cut allegations that Teva paid Amneal Pharmaceuticals Inc. not to launch its version.
-
November 07, 2024
Pantech Wants $1M Verdict Tripled In OnePlus Patent Case
Pantech Corp. wants its almost $1 million damages win tripled against Chinese phone company OnePlus Technology Shenzhen Co. Ltd. in a patent suit over technology used to comply with 5G wireless standards, while OnePlus said it shouldn't have to pony up any damages.
-
November 07, 2024
NC State '83 Team Fights 'Absurd' NCAA Bid To Toss NIL Suit
The NCAA's ongoing use of the 1983 North Carolina State University basketball team's championship highlights in promotions and marketing negates its claim that any allegations of name, image and likeness misuse are past the statute of limitations, the team's players told a North Carolina state court Wednesday.
Expert Analysis
-
It's No Longer Enough For Firms To Be Trusted Advisers
Amid fierce competition for business, the transactional “trusted adviser” paradigm from which most firms operate is no longer sufficient — they should instead aim to become trusted partners with their most valuable clients, says Stuart Maister at Strategic Narrative.
-
Breaking Down Director Review Timing At The PTAB
Attorneys at Fish & Richardson examine the complexities of director review of a Patent Trial and Appeal Board ruling, including timelines for requests and decisions, and how these factors influence related district court cases.
-
Calif. Bill, NTIA Report Illustrate Open-Model AI Safety Debate
The National Telecommunications and Information Administration’s balanced recommendations for preventing misuse of open artificial intelligence models, contrasted with a more aggressive California bill, demonstrate an evolving regulatory debate about balancing democratic access to this powerful new technology against potential risks to the public, say Stuart Meyer and Fredrick Tsang at Fenwick.
-
Behind 3rd Circ. Ruling On College Athletes' FLSA Eligibility
The Third Circuit's decision that college athletes are not precluded from bringing a claim under the Fair Labor Standards Act raises key questions about the practical consequences of treating collegiate athletes as employees, such as Title IX equal pay claims and potential eligibility for all employment benefits, say attorneys at Debevoise.
-
Patent Lessons From 4 Federal Circuit Reversals In July
The Federal Circuit’s July reversal of four cases, all of which were Patent Trial and Appeal Board decisions, highlights lessons for patent practitioners regarding the scope of estoppel provisions, potential issues with obtaining certain substitute claims, and more, say Denise De Mory and Li Guo at Bunsow De Mory.
-
Video Game Release Highlights TM Pitfalls Of App Store
The upcoming release of poker video game Balatro in Apple's App Store underscores the tradeoff of keyword advertising and trademark protection for indie developers who, unlike corporate counterparts, lack resources but seek to maximize the reach of their game, say Parmida Enkeshafi and Simon Pulman at Pryor Cashman.
-
5 Credibility Lessons Trial Attys Can Learn From Harris' Run
In launching a late-stage campaign for president, Vice President Kamala Harris must seize upon fresh attention from voters to establish, or reestablish, credibility — a challenge that parallels and provides takeaways for trial attorneys, says Ken Broda-Bahm at Persuasion Strategies.
-
Patent Owner Estoppel Questions In The Wake Of SoftView
The U.S. Patent and Trademark Office's seldom-litigated Rule 42.73(d)(3) on Patent Trial and Appeal Board estoppel was recently brought to the forefront in the Federal Circuit's SoftView v. Apple decision, highlighting uncertainties in this aspect of patent practice, say David Haars and Richard Crudo at Sterne Kessler.
-
Copyright Termination Opinion Departs From Long-Held Views
In Vetter v. Resnik, a federal court recently held for the first time that termination rights under Section 304 of the Copyright Act recapture domestic and foreign rights where the original grant was for "worldwide" rights — misinterpreting a basic principle of international copyright treaties, say Rebecca Benyamin and Eric J. Schwartz at Mitchell Silberberg.
-
3 Patent Considerations For America's New Quantum Hub
Recent developments signal an incredibly bright future for Chicago as the new home of quantum computing, and it is crucial that these innovators — whose technology has the potential to transform many industries — prioritize intellectual property strategy, says Andrew Velzen at McDonnell Boehnen.
-
Fed. Circ. Ruling Creates New Rule For Certification Marks
The Federal Circuit's decision last month in Bureau National Interprofessionnel du Cognac v. Cologne & Cognac Entertainment is significant in that it establishes a new standard for assessing evidence of third-party uses of a certification mark in deciding whether the mark is famous, say Samantha Katze and Lisa Rosaya at Manatt.
-
A Preview Of AI Priorities Under The Next President
For the first time in a presidential election, both of the leading candidates and their parties have been vocal about artificial intelligence policy, offering clues on the future of regulation as AI continues to advance and congressional action continues to stall, say attorneys at Mintz.
-
11 Patent Cases To Watch At Fed. Circ. And High Court
As we head into fall, there are 11 patent cases to monitor, touching on a range of issues that could affect patent strategy, such as biotech innovation, administrative rulemaking and patent eligibility, say Edward Lanquist and Wesley Barbee at Baker Donelson.
-
Why India May Become A Major Patent Litigation Forum
India is reinventing itself with the goal of becoming a global hot spot for patent litigation, with recent developments at the Delhi High Court creating incentives for plaintiffs to assert patent rights in India, say Ranganath Sudarshan at Covington and IP litigator Udit Sood.
-
Opinion
To Lower Drug Prices, Harris Must Address Patent Thickets
If Vice President Kamala Harris is serious about her pledge to address high drug prices, she must begin by closing loopholes that allow pharmaceutical companies to develop patent thickets that can deter generic or biosimilar companies from entering the market, says Tahir Amin at the Initiative for Medicines, Access & Knowledge.